Predicting Method for the Human Plasma Concentration–Time Profile of a Monoclonal Antibody from the Half-life of Non-human Primates-Reference-Cited by-同舟云学术

Predicting Method for the Human Plasma Concentration–Time Profile of a Monoclonal Antibody from the Half-life of Non-human Primates

Published:2020-05-01 Issue:5 Volume:43 Page:823-830
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Nakamura Genki¹²,Ozeki Kazuhisa¹,Nagayasu Miho¹,Nambu Takeru¹,Nemoto Takayuki¹,Hosoya Ken-ichi²

Affiliation:

1. Research Division, Chugai Pharmaceutical Co., Ltd.

2. Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/43/5/43_b19-01042/_pdf

Reference72 articles.

1. 1) Iwasaki K, Uno Y, Utoh M, Yamazaki H. Importance of cynomolgus monkeys in development of monoclonal antibody drugs. Drug Metab. Pharmacokinet., 34, 55–63 (2019).

2. 2) Raje AA, Mahajan V, Pathade VV, Joshi K, Gavali A, Gaur A, Kandikere V. Capillary microsampling in mice: effective way to move from sparse sampling to serial sampling in pharmacokinetics profiling. Xenobiotica, 1, 1–7 (2019).

3. 3) Che J, Wang H, Chen Z, Li X, Hou Y, Shan C, Cheng Y. A new approach for pharmacokinetics of single-dose cetuximab in rhesus monkeys by surface plasmon resonance biosensor. J. Pharm. Biomed. Anal., 50, 183–188 (2009).

4. 4) Nnane IP, Xu Z, Zhou H, Davis HM. Non-clinical pharmacokinetics, prediction of human pharmacokinetics and first-in-human dose selection for CNTO 5825, an anti-interleukin-13 monoclonal antibody. Basic Clin. Pharmacol. Toxicol., 117, 219–225 (2015).

5. 5) Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, Vidal JM, van de Vorstenbosch C. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol., 21, 15–23 (2001).

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of human serum concentration–time profiles of therapeutic monoclonal antibodies using common marmosets ( Callithrix jacchus ): initial assessment with canakinumab, adalimumab, and bevacizumab;Xenobiotica;2024-07-26

2. Development of a New Method to Evaluate the Biodistribution of Antibodies Using Non-Radioactive Metal Labeling and Inductively Coupled Plasma Mass Spectrometry;Pharmaceutical Research;2023-06-02

3. Review of the Existing Translational Pharmacokinetics Modeling Approaches Specific to Monoclonal Antibodies (mAbs) to Support the First-In-Human (FIH) Dose Selection;International Journal of Molecular Sciences;2022-10-22

4. Developing a computational pharmacokinetic model of systemic snakebite envenomation and antivenom treatment;Toxicon;2022-08

5. Combination of cassette-dosing and microsampling for reduced animal usage for antibody pharmacokinetics in cynomolgus monkeys, wild-type mice, and human FcRn transgenic mice;Pharmaceutical Research;2021-03-29